Search

Your search keyword '"Arısoy, Ayşe Engin"' showing total 125 results
Start Over Author "Arısoy, Ayşe Engin"
125 results on '"Arısoy, Ayşe Engin"'

2. Congenital Rubella Infection and Hearing Loss

Author

Gayretli Aydın, Zeynep Gökçe, Arısoy, Ayşe Engin, Demmler-Harrison, Gail J., Cingi, Cemal, Series Editor, Arısoy, Ayşe Engin, editor, Arısoy, Emin Sami, editor, Bayar Muluk, Nuray, editor, and Correa, Armando G., editor

Published
2023
Full Text
View/download PDF

3. Congenital Toxoplasmosis and Hearing Loss

Author

Kepenekli, Eda, Arısoy, Ayşe Engin, Arısoy, Emin Sami, Correa, Armando G., Cingi, Cemal, Series Editor, Arısoy, Ayşe Engin, editor, Arısoy, Emin Sami, editor, Bayar Muluk, Nuray, editor, and Correa, Armando G., editor

Published
2023
Full Text
View/download PDF

8. Congenital Syphilis and Hearing Loss

Author

Kara, Emine Manolya, Arısoy, Ayşe Engin, Rochat, Ryan Henry, Cingi, Cemal, Series Editor, Arısoy, Ayşe Engin, editor, Arısoy, Emin Sami, editor, Bayar Muluk, Nuray, editor, and Correa, Armando G., editor

Published
2023
Full Text
View/download PDF

15. Otitis Media in Infants

Author

Atan Şahin, Özlem Naciye, Bayar Muluk, Nuray, Arısoy, Ayşe Engin, Cingi, Cemal, editor, Arısoy, Emin Sami, editor, and Bayar Muluk, Nuray, editor

Published
2022
Full Text
View/download PDF

28. Management of hypoglycemia in newborn: Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies consensus report

Author

Mutlu, Gül Yeşiltepe (ORCID 0000-0003-3919-7763 & YÖK ID 153511), Aliefendioğlu, Didem; Çoban, Asuman; Hatipoğlu, Nihal; Ecevit, Ayşe; Arısoy, Ayşe Engin; Baş, Firdevs; Bideci, Aysun; Özek, Eren, School of Medicine, Department of Pediatrics, Mutlu, Gül Yeşiltepe (ORCID 0000-0003-3919-7763 & YÖK ID 153511), Aliefendioğlu, Didem; Çoban, Asuman; Hatipoğlu, Nihal; Ecevit, Ayşe; Arısoy, Ayşe Engin; Baş, Firdevs; Bideci, Aysun; Özek, Eren, School of Medicine, and Department of Pediatrics

Abstract

Hypoglycemia is one of the most important and most common metabolic problems of the newborn because it poses a risk of neurological injury, if it is prolonged and recurs. Therefore, newborns who carry a risk of hypoglycemia should be fed immediately after delivery and the blood glucose level should be measured with intervals of 2-3 hours from the 30th minute alter feeding. The threshold value for hypoglycemia is 40 mg/dL for the first 24 hours in symptomatic babies. In asymptomatic babies, this value is considered 25 mg/dL for 0-4 hours, 35 mg/dl for 4-24 hours, 50 mg/dL alter 24 hours and 60 mg/dL after 48 hours. Screening should be performed with bed-side test sticks. When values near the limit value are obtained, confirmation with laboratory method should be done and treatment should be initiated, if necessary. The level targeted with treatment is considered 50 mg/dL in the postnatal first 48 hours before feeding, 60 mg/dL after 48 hours in babies with high risk and above 70 mg/dL in babies with permanent hypoglycemia. In cases in which the blood glucose level is below the threshold value and can not be increased by feeding, a glucose infusion of 6-8 mg/kg/min should be initiated. If symptoms accompany, a mini bolus of 10% dextrose (2 ml/kg/min) should accompany. Incements (2 mg/kg/min) should be performed, if the target level can not be achieved and decrements (2 ml/kg/min) should be performed, if nutrition and stabilization is provided. The infusion should be discontinued, if the infusion rate decreases to 3-5 mg/kg/min. If necessary, blood samples should be obtained during hypoglycemia in terms of differential diagnosis and the investigation should be performed following a 6-hour fasting period in babies fed enterally and at any time when the plasma glucose is <50 mg/dL in babies receiving parenteral infusion. The hypoglycemic babies in the risk group whose infusions have been terminated can be discharged, if the plasma glucose level is found to be at the targ, NA

Published
2019

29. Comparison of LISA vs INSURE Technique Using Nasal Intermittent Positive Pressure Ventilation (NIPPV) Support In Preterm Infants: A Randomized Controlled Trial.

Author

Akcay, Nihal, Gökalp, Ayşe Sevim, Günlemez, Ayla, Oğuz, Demet, Kılıçbay, Fatih, and Arısoy, Ayşe Engin

Subjects
PREMATURE infant disease prevention, LUNG injuries, EVALUATION of medical care, PULMONARY surfactant, ACADEMIC medical centers, PREMATURE infants, ENDOSCOPIC surgery, HEALTH outcome assessment, RANDOMIZED controlled trials, DECOMPRESSION sickness, CARBON dioxide, STATISTICAL sampling, INTERMITTENT positive pressure breathing, TRACHEA intubation, PARTIAL pressure, EVALUATION
Abstract

Copyright of Medical Journal of Bakirkoy is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2021
Full Text
View/download PDF

30. Neonatal Hyperglycemia, which threshold value, diagnostic approach and treatment?:Turkish Neonatal and Pediatric Endocrinology and Diabetes Societies consensus report

Author

Mutlu, Gül Yeşiltepe (ORCID 0000-0003-3919-7763 & YÖK ID 153511), Şimşek, Damla Gökşen; Ecevit, Ayşe; Hatipoğlu, Nihal; Çoban, Asuman; Arısoy, Ayşe Engin; Baş, Firdevs; Bideci, Aysun; Özek, Eren, School of Medicine, Department of Pediatrics, Mutlu, Gül Yeşiltepe (ORCID 0000-0003-3919-7763 & YÖK ID 153511), Şimşek, Damla Gökşen; Ecevit, Ayşe; Hatipoğlu, Nihal; Çoban, Asuman; Arısoy, Ayşe Engin; Baş, Firdevs; Bideci, Aysun; Özek, Eren, School of Medicine, and Department of Pediatrics

Abstract

Hyperglycemia has become an important risk factor for mortality and morbidity in the neonatal period, especially with increased survival rates of very low birth weight neonates. Hyperglycemia in the neonatal period develops as a result of various mechanisms including iatrogenic causes, inability to supress hepatic glucose production, insulin resistance or glucose intolerance, specifically in preterm neonates. Initiation of parenteral or enteral feeding in the early period in preterm babies increases insulin production and sensitivity. The plasma glucose is targeted to be kept between 70 and 150 mg/dL in the newborn baby. While a blood glucose value above 150 mg/dL is defined as hyperglycemia, blood glucose values measured with an interval of 4 hours of >180-200 mg/dL and +2 glucosuria require treatment. Although glucose infusion rate is reduced in treatment, use of insulin is recommended, if two blood glucose values measured with an interval of 4 hours are >250 mg/dL and glucosuria is present in two separate urine samples. / Yenidoğan döneminde özellikle çok düşük doğum ağırlıklı bebeklerin yaşamda kalmaya başlamaları ile birlikte, hiperglisemi morbidite ve mortalite için önemli bir risk etmeni olmuştur. Yenidoğan döneminde özellikle preterm bebeklerde hiperglisemi, iyatrojenik nedenler, karaciğerde glukoz üretiminin baskılanamaması, insülin direnci ya da glukoz intoleransı gibi mekanizmalar sonucu gelişmektedir. Preterm bebeklerin erken dönemde parenteral ya da enteral beslenmeye başlanması; insülin yapımını ve duyarlılığını arttırır. Yenidoğan bebekte kan şekerinin 70-150 mg/dL arasında olması hedeflenmektedir. Kan şeker düzeyi >150 mg/dL olması hiperglisemi olarak tanımlanırken; 4 saat ara ile bakılan kan şekerinin >180-200 mg/dL olması ve +2 glukozüri olması tedaviyi gerektirmektedir. Tedavide glukoz infüzyon hızı azaltılmasına rağmen; 4 saat ara ile bakılan 2 kan şekeri değeri >250 mg/dL ve alınan iki ayrı idrar örneğinde glukozüri varsa insülin kullanılması ön, NA

Published
2018

32. Geç preterm doğmuş çocukların okul öncesi dönemde akciğer işlevlerinin değerlendirilmesi.

Author

Er, İlkay, Günlemez, Ayla, Uyan, Zeynep Seda, Aydoğan, Metin, Oruç, Meral, Işık, Olcay, Arısoy, Ayşe Engin, Baydemir, Canan, and Gökalp, Ayşe Sevim

Abstract

Copyright of Türk Pediatri Arşivi is the property of Aves Yayincilik Ltd. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2017
Full Text
View/download PDF

38. Kawasaki Disease and Hearing Loss

Author

Başar, Eviç Zeynep, Babaoğlu, Kadir, Yildirim-Toruner, Cagri, Cingi, Cemal, Series Editor, Arısoy, Ayşe Engin, editor, Arısoy, Emin Sami, editor, Bayar Muluk, Nuray, editor, and Correa, Armando G., editor

Published
2023
Full Text
View/download PDF

40. Prion Diseases and Hearing Loss

Author

Zirek, Alaattin, Küçük, Nurten, Bayar Muluk, Nuray, Cingi, Cemal, Series Editor, Arısoy, Ayşe Engin, editor, Arısoy, Emin Sami, editor, Bayar Muluk, Nuray, editor, and Correa, Armando G., editor

Published
2023
Full Text
View/download PDF

47. Lassa Fever and Hearing Loss

Author

Gündoğan, Fatih, Cihan, Celalettin, Jovancevic, Ljiljana, Cingi, Cemal, Series Editor, Arısoy, Ayşe Engin, editor, Arısoy, Emin Sami, editor, Bayar Muluk, Nuray, editor, and Correa, Armando G., editor

Published
2023
Full Text
View/download PDF

50. COVID-19 in Children and Hearing Loss

Author

Bozan, Nazım, Cingi, Cemal, Passali, Francesco Maria, Cingi, Cemal, Series Editor, Arısoy, Ayşe Engin, editor, Arısoy, Emin Sami, editor, Bayar Muluk, Nuray, editor, and Correa, Armando G., editor

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results